Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
US9149459B2 · kind B2 · utility
1Cited by
4References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2009 |
| Grant date | Oct 6, 2015 |
| Priority date | — |
| Expiry date | May 24, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of an S1P receptor modulator of the formula (Ia) or (Ib) wherein the meaning of the different residues is that indicated in claim 14, in the preparation of a medicament for preventing, inhibiting or treating an inflammatory condition selected from polymyositis, dermatomyositis and nerve-muscle diseases e.g. muscular dystrophies and inclusion body myositis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.